Literature DB >> 35305814

Association of infertility with atherosclerotic cardiovascular disease among postmenopausal participants in the Women's Health Initiative.

Gayathree Murugappan1, Stephanie A Leonard2, Leslie V Farland3, Emily S Lau4, Aladdin H Shadyab5, Robert A Wild6, Peter Schnatz7, Suzan L Carmichael8, Marcia L Stefanick9, Nisha I Parikh10.   

Abstract

OBJECTIVE: To investigate the association of infertility with atherosclerotic cardiovascular disease (ASCVD) among postmenopausal participants in the Women's Health Initiative (WHI). We hypothesized that nulliparity and pregnancy loss may reveal more extreme phenotypes of infertility, enabling further understanding of the association of infertility with ASCVD.
DESIGN: Prospective cohort study.
SETTING: Forty clinical centers in the United States. PATIENT(S): A total of 158,787 postmenopausal participants in the Women's Health Initiative cohort. INTERVENTION(S): Infertility, parity, and pregnancy loss. MAIN OUTCOME MEASURE(S): The primary outcome was risk of ASCVD among women with and without a history of infertility, stratified by history of live birth and pregnancy loss. Cox proportional-hazards models were adjusted for demographics and risk factors for ASCVD. RESULT(S): Among 158,787 women, 25,933 (16.3%) reported a history of infertility; 20,427 (80%) had at least 1 live birth; and 9,062 (35%) had at least 1 pregnancy loss. There was a moderate overall association between infertility and ASCVD (adjusted hazard ratio, 1.02; 95% confidence interval [CI], 0.99-1.06) over 19 years of follow-up. Among nulliparous women, infertility was associated with a 13% higher risk of ASCVD (95% CI, 1.04-1.23). Among nulliparous women who had a pregnancy loss, infertility was associated with a 36% higher risk of ASCVD (95% CI, 1.09-1.71). CONCLUSION(S): Women with a history of infertility overall had a moderately higher risk of ASCVD compared with women without a history of infertility. Atherosclerotic cardiovascular disease risk was much higher among nulliparous infertile women and among nulliparous infertile women who also had a pregnancy loss, suggesting that in these more extreme phenotypes, infertility may be associated with ASCVD risk.
Copyright © 2022 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiovascular disease; gravidity; infertility; parity; pregnancy

Mesh:

Year:  2022        PMID: 35305814      PMCID: PMC9081220          DOI: 10.1016/j.fertnstert.2022.02.005

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.490


  49 in total

1.  Outcomes ascertainment and adjudication methods in the Women's Health Initiative.

Authors:  J David Curb; Anne McTiernan; Susan R Heckbert; Charles Kooperberg; Janet Stanford; Michael Nevitt; Karen C Johnson; Lori Proulx-Burns; Lisa Pastore; Michael Criqui; Sandra Daugherty
Journal:  Ann Epidemiol       Date:  2003-10       Impact factor: 3.797

2.  Menstrual cycle irregularity and risk for future cardiovascular disease.

Authors:  Caren G Solomon; Frank B Hu; Andrea Dunaif; Janet E Rich-Edwards; Meir J Stampfer; Walter C Willett; Frank E Speizer; Joann E Manson
Journal:  J Clin Endocrinol Metab       Date:  2002-05       Impact factor: 5.958

3.  Parity and risk of later-life maternal cardiovascular disease.

Authors:  Nisha I Parikh; Sven Cnattingius; Paul W Dickman; Murray A Mittleman; Jonas F Ludvigsson; Erik Ingelsson
Journal:  Am Heart J       Date:  2010-02       Impact factor: 4.749

4.  Women's early warning symptoms of acute myocardial infarction.

Authors:  Jean C McSweeney; Marisue Cody; Patricia O'Sullivan; Karen Elberson; Debra K Moser; Bonnie J Garvin
Journal:  Circulation       Date:  2003-11-03       Impact factor: 29.690

5.  Self-reported infertility, metabolic dysfunction, and cardiovascular events: a cross-sectional analysis among U.S. women.

Authors:  Jessica L Gleason; Edmond D Shenassa; Marie E Thoma
Journal:  Fertil Steril       Date:  2018-11-17       Impact factor: 7.329

6.  Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly.

Authors:  T J McLaughlin; S B Soumerai; D J Willison; J H Gurwitz; C Borbas; E Guadagnoli; B McLaughlin; N Morris; S C Cheng; P J Hauptman; E Antman; L Casey; R Asinger; F Gobel
Journal:  Arch Intern Med       Date:  1996-04-08

Review 7.  2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Donna K Arnett; Roger S Blumenthal; Michelle A Albert; Andrew B Buroker; Zachary D Goldberger; Ellen J Hahn; Cheryl Dennison Himmelfarb; Amit Khera; Donald Lloyd-Jones; J William McEvoy; Erin D Michos; Michael D Miedema; Daniel Muñoz; Sidney C Smith; Salim S Virani; Kim A Williams; Joseph Yeboah; Boback Ziaeian
Journal:  Circulation       Date:  2019-03-17       Impact factor: 29.690

8.  Association of spontaneous abortion with all cause and cause specific premature mortality: prospective cohort study.

Authors:  Yi-Xin Wang; Lidia Mínguez-Alarcón; Audrey J Gaskins; Stacey A Missmer; Janet W Rich-Edwards; JoAnn E Manson; An Pan; Jorge E Chavarro
Journal:  BMJ       Date:  2021-03-24

9.  Association between infertility and all-cause mortality: analysis of US claims data.

Authors:  Gayathree Murugappan; Shufeng Li; Ruben J Alvero; Barbara Luke; Michael L Eisenberg
Journal:  Am J Obstet Gynecol       Date:  2021-02-10       Impact factor: 10.693

10.  Association of Adverse Pregnancy Outcomes With Risk of Atherosclerotic Cardiovascular Disease in Postmenopausal Women.

Authors:  Marc Meller Søndergaard; Mark A Hlatky; Marcia L Stefanick; Eric Vittinghoff; Gregory Nah; Matthew Allison; Alison Gemmill; Linda Van Horn; Ki Park; Elena Salmoirago-Blotcher; Maryam Sattari; Shawnita Sealy-Jefferson; Aladdin H Shadyab; Carolina Valdiviezo; JoAnn E Manson; Nisha I Parikh
Journal:  JAMA Cardiol       Date:  2020-12-01       Impact factor: 14.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.